SCHEMBL6880264

SCHEMBL6880264

CN(C)C(NC(=O)C(F)(F)F)C1CCCCC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK1 Q15118 1/20 0.39
PDK2 Q15119 1/20 0.39
PDK3 Q15120 1/20 0.39
PDK4 Q16654 1/20 0.39
CA12 O43570 2/20 0.36
CA1 P00915 2/20 0.36
CA2 P00918 2/20 0.36
MMP2 P08253 2/20 0.36
CA9 Q16790 2/20 0.36
PKM P14618 1/20 0.33
EPHX1 P07099 7/20 0.32
NR3C1 P04150 1/20 0.32
SIGMAR1 Q99720 1/20 0.32
TP53 P04637 1/20 0.31
ACACB O00763 1/20 0.31
OPRM1 P35372 1/20 0.31
NPC1 O15118 2/20 0.31
RAB9A P51151 2/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3107097 0.77 CA12 (0.54) PDK1PDK2PDK3PDK4CA12
SCHEMBL25564753 0.72 DPP4 (0.38) PDK1PDK2PDK3PDK4CA12
SCHEMBL3416246 0.72 MMP1 (0.49) PDK1PDK2PDK3PDK4MMP2
SCHEMBL25564751 0.72 TP53 (0.42) PDK1PDK2PDK3PDK4CA12
SCHEMBL25755234 0.72 CA2 (0.47) PDK1PDK2PDK3PDK4CA12
SCHEMBL8283711 0.68 PDK1 (0.34) PDK1PDK2PDK3PDK4CA12
SCHEMBL25755239 0.67 EPHX2 (0.42) CA12CA1CA2MMP2CA9
SCHEMBL25076151 0.67 PKM (0.35) PDK1PDK2PDK3PDK4CA2
SCHEMBL14074440 0.67 PDK1 (0.33) PDK1PDK2PDK3PDK4CA12
SCHEMBL12203914 0.67 CTSK (0.50) PDK1PDK2PDK3PDK4EPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1476151-A1 1-ARYLSULFONYL-3-SUBSTITUED INDOLE AND INDOLINE DERIVATES USEFUL IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS Akzo Nobel N.V. (NL) 2004-11-17 EP disclosed
WO-2003068220-A1 1-ARYLSULFONYL-3-SUBSTITUTED INDOLE AND INDOLINE DERIVATIVES USEFUL IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS AKZO NOBEL N.V. (NL) 2003-08-21 WO disclosed